The cancer biomarkers industry is witnessing rapid expansion, driven by ongoing advancements in diagnostic and therapeutic technologies. The integration of precision medicine and early detection tools has notably intensified business growth, positioning this market at the forefront of oncology innovation. https://hallbook.com.br/blogs/823900/Cancer-Biomarkers-Market-Growth-Fueled-by-Innovative-Diagnostic-Advancements